Monocentric Trial: Stem Cell Emergency Life Threatening Limbs Arteriopathy (SCELTA)

NCT02454231 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Critical Limb Ischemia

Interventions

BIOLOGICAL: Transplantation of circulating CD14+CD34+cells
BIOLOGICAL: Transplantation of BM MNC

Sponsor

University of Florence

Collaborators

[object Object]